Germinoma
-
Subject Areas on Research
- Characterization of gains, losses, and regional amplification in testicular germ cell tumor cell lines by comparative genomic hybridization.
- DNA ploidy in nonseminomatous germ cell testicular tumor.
- Dendritic cells activate antitumor immunity for malignant intracranial germ cell tumor: a case report.
- Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma.
- Efficacy of radiographic chest imaging in patients with testicular cancer.
- High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study.
- Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours.
- Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors.
- Immunohistochemical expression of P53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage I disease.
- Immunohistochemical expression of P53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage I disease.
- Immunohistochemical expression of monoclonal antibody 43-9F in testicular germ cell tumours.
- Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors.
- Induction of tumor necrosis factor-alpha as a cause of bleomycin-related toxicity.
- Management of pineal non-germinoma germ cell tumor with residual teratoma and normal alpha-fetoprotein.
- Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
- Molecular genetic parameters in pathogenesis and prognosis of testicular germ cell tumors.
- Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage I nonseminomatous testicular cancer.
- Nongenital granuloma inguinale in an oncology patient.
- Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.
- Pineal epidermoid cysts.
- Prognostic factors in low-stage nonseminomatous testicular cancer.
- Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease.
- Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease.
- Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
- Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors.
- Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors.
- Solitary fibrous tumor of the meninges occurring after irradiation of a mixed germ cell tumor of the pineal gland.
- Stem-cell transplantation for the treatment of advanced solid tumors.
- Synchronous bilateral testicular tumour: nonseminomatous germ cell tumours and contralateral benign tumours.
- Synchronous bilateral testis tumor: mixed germ cell and theca cell tumors.
- Testicular microlithiasis and subsequent development of metastatic germ cell tumor.
- Thymic hyperplasia in newly diagnosed testicular germ cell tumors.
- Update on late relapse of germ cell tumor: a clinical and molecular analysis.